Hans-Peter Brunner-La Rocca


Prof. Hans-Peter Brunner-La Rocca has graduated in medicine at the University of Zurich, Switzerland. He was trained in Internal Medicine and Cardiology in Switzerland. After doing a post-doc in Melbourne, Australia, for two years, he had been working as cardiologist and heart failure specialist in Zurich. In 2002, he moved to Basel, where he was responsible for the heart failure and heart transplant services. He has obtained his lecture qualification both in Zurich and in Basel and was announced as Professor in Basel Switzerland in 2008. Since 2009, he has been working at Maastricht UMC+ as Professor of Clinical Heart Failure. He is head of the heart failure clinic and head of the division of structural heart diseases.

He has been involved in numerous research projects since many years. In particular, he has a special interest in personalised medicine in heart failure using biomarkers and has successfully led international studies related to this topic. In addition, eHealth is an important focus of research. He has published >250 research articles.

He has been working as member of different working groups of the Heart Failure Association of the European Society of Cardiology and is board member of working group on heart failure in the Netherlands.

On the one hand, he is continuing his research on biomarker in heart failure for therapy guidance. He is collaborating internationally on this topic and is participating in several large international projects in this regard. On the other hand, he is leading an international consortium, aiming to develop a personalized eHealth application to enable patients with heart failure to perform self-care, i.e. including self-prescription of medication. Recently, the consortium received 4.4 M€ to support this project from INTERREG-NWE (budget Maastricht UMC+ > 2.0 M€).

He is additionally involved in national research projects (e.g. heart-brain connection, supported by CVON) and is the local PI of several large industry sponsored RCTs. In one of them, he is the national coordinator for the Netherlands.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
Room number: 3.B2.031
T: +31(0)43 387 70 97

  • 2022
    • Veugen, M. G. J., Onete, V. G., Henry, R. M. A., Brunner-La Rocca, H-P., Koster, A., Dagnelie, P. C., Schaper, N. C., Sep, S. J. S., van der Kallen, C. J. H., van Boxtel, M. P. J., Reesink, K. D., Schouten, J. S., Savelberg, H. H. C. M., Köhler, S., Verhey, F. R., van den Bergh, J. P. W., Schram, M. T., & Stehouwer, C. D. A. (2022). Health burden in type 2 diabetes and prediabetes in The Maastricht Study. Scientific Reports, 12(1), 1-11. [7337]. https://doi.org/10.1038/s41598-022-11136-5
    • Ferreira, J. P., Collier, T., Clark, A. L., Mamas, M. A., Rocca, H-P. B-L., Heymans, S., González, A., Ahmed, F. Z., Petutschnigg, J., Mujaj, B., Cuthbert, J., Rouet, P., Pellicori, P., Mariottoni, B., Cosmi, F., Edelmann, F., Thijs, L., Staessen, J. A., Hazebroek, M., ... Zannad, F. (2022). Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. https://doi.org/10.1093/ehjcvp/pvab031
    • van Dalen, D. H., Kragten, J. A., Emans, M. E., Van Ofwegen-Hanekamp, C. E. E., Klaarwater, C. C. R., Spanjers, M. H. A., Hendrick, R., van Deursen, C. T. B. M., & Brunner-La Rocca, H. P. (2022). Acute heart failure and iron deficiency: a prospective, multicentre, observational study. Esc heart failure, 9(1), 398-407. https://doi.org/10.1002/ehf2.13737
    • Uszko-Lencer, N. H. M. K., Janssen, D. J. A., Gaffron, S., Vanfleteren, L. E. G. W., Janssen, E., Werter, C., Franssen, F. M. E., Wouters, E. F. M., Rechberger, S., Brunner La Rocca, H-P., & Spruit, M. A. (2022). Clustering based on comorbidities in patients with chronic heart failure: an illustration of clinical diversity. Esc heart failure, 9(1), 614-626. https://doi.org/10.1002/ehf2.13704
    • Radhoe, S. P., Veenis, J. F., Linssen, G. C. M., van der Lee, C., Eurlings, L. W. M., Kragten, H., Al-Windy, N. Y. Y., van der Spank, A., Koudstaal, S., Brunner-La Rocca, H. P., & Brugts, J. J. (2022). Diabetes and treatment of chronic heart failure in a large real-world heart failure population. Esc heart failure, 9(1), 353-362. https://doi.org/10.1002/ehf2.13743
    • de Boer, A. R., Vaartjes, I., Gohar, A., Valk, M. J. M., Brugts, J. J., Boonman-de Winter, L. J. M., van Riet, E. E., van Mourik, Y., Brunner-La Rocca, H. P., Linssen, G. C. M., Hoes, A. W., Bots, M. L., den Ruijter, H. M., & Rutten, F. H. (2022). Heart failure with preserved, mid-range, and reduced ejection fraction across health care settings: an observational study. Esc heart failure, 9(1), 363-372. https://doi.org/10.1002/ehf2.13742
    • Ament, S. M. C., van den Broek, L. M., Van den Beuken-van Everdingen, M. H. J., Boyne, J. J. J., Maessen, J. M. C., Bekkers, S. C. A. M., Bellersen, L., Brunner-La Rocca, H. P., Engels, Y., & Janssen, D. J. A. (2022). What to consider when implementing a tool for timely recognition of palliative care needs in heart failure: a context-based qualitative study. BMC Palliative Care, 21(1), [1]. https://doi.org/10.1186/s12904-021-00896-y
    • Baldewijns, K., Boyne, J., de Maesschalck, L., Deville, A., Brandenburg, V., & Brunner-La-Rocca, H. P. (2022). From guideline to daily practice: Implementation of ESC-guidelines considering multidisciplinary and non-pharmacological care in heart failure in three ESC member states, a case study. JRSM Cardiovascular Disease, 11, 1-7. https://doi.org/10.1177/20480040221074598
    • Weerts, J., Barandiarán Aizpurua, A., Henkens, M. T. H. M., Lyon, A., van Mourik, M. J. W., van Gemert, M. R. A. A., Raafs, A., Sanders-van Wijk, S., Bayés-Genís, A., Heymans, S. R. B., Crijns, H. J. G. M., Brunner-La Rocca, H-P., Lumens, J., van Empel, V. P. M., & Knackstedt, C. (2022). The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction. European Heart Journal Cardiovascular Imaging, 23(1), 74-84. https://doi.org/10.1093/ehjci/jeab222
  • 2021
    • Verdonschot, J. A. J., Ferreira, J. P., Pizard, A., Pellicori, P., Brunner La Rocca, H-P., Clark, A. L., Cosmi, F., Cuthbert, J., Girerd, N., Waring, O. J., Henkens, M. H. T. M., Mariottoni, B., Petutschnigg, J., Rossignol, P., Hazebroek, M. R., Cleland, J. G. F., Zannad, F., Heymans, S. R. B., & HOMAGE “Heart Omics in AGEing” consortium (2021). The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2021.12.005